HSV-1, Herpes simplex virus type 1

HSV - 1 , 单纯疱疹病毒 1 型
  • 文章类型: Journal Article
    UNASSIGNED:Descemet的膜内皮角膜移植术(DMEK)正在成为世界范围内治疗角膜内皮功能障碍的金标准。与传统穿透性角膜移植术相比,DMEK后的感染性并发症定义不明确。我们描述了2名DMEK接受者的临床表现,在同一天和同一诊所手术,在DMEK后几天内在移植受者的眼睛中出现非典型单纯疱疹病毒1型(HSV-1)感染。因为接受者接受了来自同一眼库准备的2个不同供体的角膜组织,确定了常见HSV-1来源的可能性.
    未经评估:案例系列。
    UNASSIGNED:两名在手术后不久出现非典型眼内HSV-1病的DMEK受者和6名供体的剩余角膜标本。
    UNASSIGNED:通过实时聚合酶链反应(RT-PCR)和细胞培养分析剩余角膜供体(DMEK前角膜残留物和条件角膜储存和运输培养基)和受体样品(DMEK后房水)的HSV-1DNA和感染性病毒,分别。对HSV-1DNA阳性眼部标本进行靶富集的全病毒基因组测序。
    UNASSIGNED:DMEK后非典型眼内HSV-1感染的临床表现以及DMEK供者和受者眼标本之间HSV-1基因组的存在和同源性.
    未经证实:在两个DMEK病例的房水和供体角膜标本中检测到1型单纯疱疹病毒DNA,但不在由同一眼库处理的6个随机选择的供体的角膜残余物中。从1个角膜供体的角膜残余物和相应的培养基中分离感染性HSV-1。值得注意的是,病毒DNA阳性标本的全基因组测序表明,两种DMEK病例的受体和供体标本中HSV-1株之间的遗传相似性非常高.
    UASSIGNED:数据表明在DMEK制备过程中角膜移植物交叉污染,随后移植物向宿主传播HSV-1,在DMEK后不久引起非典型的危及视力的疱疹性眼病。眼科医生应该意识到,通过DMEK传播HSV-1是可能的,并可能导致非典型眼病,通过在眼库和手术水平上采取适当的技术和临床措施,可以很容易地预防这种情况。
    UNASSIGNED: Descemet\'s membrane endothelial keratoplasty (DMEK) is becoming the gold standard to treat corneal endothelial dysfunctions worldwide. Compared with conventional penetrating keratoplasty, infectious complications after DMEK are ill defined. We describe the clinical picture of 2 DMEK recipients, operated on the same day and in the same clinic, who developed atypical herpes simplex virus type 1 (HSV-1) infection in the transplant recipient eye within days post-DMEK. Because recipients received cornea tissue from 2 different donors prepared by the same eye bank, the likelihood of a common HSV-1 source was determined.
    UNASSIGNED: Case series.
    UNASSIGNED: Two DMEK recipients who developed atypical intraocular HSV-1 disease shortly after surgery and surplus cornea specimens of 6 donors.
    UNASSIGNED: Surplus cornea donor (pre-DMEK cornea remnants and conditioned cornea storage and transport media) and recipient samples (post-DMEK aqueous humor) were assayed for HSV-1 DNA and infectious virus by real-time polymerase chain reaction (RT-PCR) and cell culture, respectively. Target-enriched whole viral genome sequencing was performed on HSV-1 DNA-positive ocular specimens.
    UNASSIGNED: Clinical picture of atypical intraocular HSV-1 infection post-DMEK and presence and homology of HSV-1 genomes between ocular specimens of DMEK donors and recipients.
    UNASSIGNED: Herpes simplex virus type 1 DNA was detected in aqueous humor and donor cornea specimens of both DMEK cases, but not in the cornea remnants of 6 randomly selected donors processed by the same eye bank. Infectious HSV-1 was isolated from the cornea remnant and corresponding culture medium of 1 cornea donor. Notably, whole-genome sequencing of virus DNA-positive specimens demonstrated exceptionally high genetic similarity between HSV-1 strains in recipient and donor specimens of both DMEK cases.
    UNASSIGNED: Data indicate cross-contamination of cornea grafts during DMEK preparation with subsequent graft-to-host HSV-1 transmission that caused atypical sight-threatening herpetic eye disease shortly after DMEK. Ophthalmologists should be aware that HSV-1 transmission by DMEK is possible and can lead to atypical ocular disease, a condition that can easily be prevented by taking appropriate technical and clinical measures at both eye bank and surgical levels.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

  • 文章类型: Journal Article
    未经批准:2019年12月,一种新型冠状病毒,SARS-CoV-2在全球范围内引起一系列急性非典型呼吸道疾病。然而,仍然缺乏疗效明确的药物,疫苗的临床试验研究尚未完全完成。
    UASSIGNED:LH胶囊是批准的中药成药,广泛用于治疗由感冒和流感引起的呼吸道传染病。2020年4月12日,根据通过多中心证明的安全性和有效性,中国食品药品监督管理局(CFDA)正式将LH胶囊和颗粒重新用于轻度COVID-19患者,随机化,对照临床试验。我们希望通过现代药学方法对其进行全面回顾,并试图解释其可能的机制。
    未经授权:使用连花清温黄体胶囊的全称,连花清温和SARS-COV-2、COVID-19作为搜索词的关键词,在各种数据库(如WebofScience和PubMed)中系统地搜索现有的相关论文。并在ClinicalTrials.gov和中国临床试验注册中心完成了临床数据的收集。最后但并非最不重要的,我们通过文献和Selleck整理了LH胶囊的抗炎和抗病毒机制。
    UNASSIGNED:这篇综述系统地梳理了LH胶囊中的活性成分。此外,详细讨论了LH胶囊对SARS-CoV-2,IAV和IBV的相关药理和临床试验。此外,本综述首次概述了LH胶囊中特定物质参与SARS-COV-2感染抗性和抑制IL-6引起的细胞因子风暴综合征(CSS)的潜在分子机制。
    UNASSIGNED:本综述总结了支持使用LH胶囊作为预防和治疗COVID-19的潜在候选药物的现有报告和证据。然而,中医通过多靶点、多途径发挥作用,LH胶囊也不例外。因此,相关机制有待进一步完善和实验验证。
    UNASSIGNED: In December 2019, a novel coronavirus, SARS-CoV-2 caused a series of acute atypical respiratory diseases worldwide. However, there is still a lack of drugs with clear curative effects, and the clinical trial research of vaccines has not been completely finished.
    UNASSIGNED: LH capsules are approved TCM patent medicine that are widely used for the treatment of respiratory tract infectious diseases caused by colds and flu. On April 12, 2020, LH capsules and granules were officially repurposed by the China Food and Drug Administration (CFDA) for patients with mild COVID-19 based on their safety and efficacy demonstrated through multicentre, randomized, controlled clinical trials. We hope to conduct a comprehensive review of it through modern pharmacy methods, and try to explain its possible mechanism.
    UNASSIGNED: Using the full names of LH capsules Lianhuaqingwen, Lianhua Qingwen andSARS-COV-2, COVID-19 as the keywords of the search terms, systemically search for existing related papers in various databases such as Web of Science and PubMed. And completed the collection of clinical data in ClinicalTrials.gov and Chinese Clinical Trial Registry. Last but not least, we have sorted out the anti-inflammatory and antiviral mechanisms of LH capsules through literature and Selleck.
    UNASSIGNED: This review systematically sorted out the active ingredients in LH capsules. Furthermore, the related pharmacological and clinical trials of LH capsule on SARS-CoV-2, IAV and IBV were discussed in detail. Moreover, the present review provides the first summary of the potential molecular mechanism of specific substances in LH capsules involved in resistance to SARS-COV-2 infection and the inhibition of cytokine storm syndrome (CSS) caused by IL-6.
    UNASSIGNED: This review summarizes the available reports and evidence that support the use of LH capsules as potential drug candidates for the prevention and treatment of COVID-19. However, TCM exerts its effects through multiple targets and multiple pathways, and LH capsules are not an exception. Therefore, the relevant mechanisms need to be further improved and experimentally verified.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

  • 文章类型: Case Reports
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    Herpes simplex virus type 1 (HSV-1), a neurotropic herpes virus, is able to establish a lifelong latent infection in the human host. Following primary replication in mucosal epithelial cells, the virus can enter sensory neurons innervating peripheral tissues via nerve termini. The viral genome is then transported to the nucleus where it can be maintained without producing infectious progeny, and thus latency is established in the cell. Yin-Yang balance is an essential concept in traditional Chinese medicine (TCM) theory. Yin represents stable and inhibitory factors, and Yang represents the active and aggressive factors. When the organism is exposed to stress, especially psychological stress caused by emotional stimulation, the Yin-Yang balance is disturbed and the virus can re-engage in productive replication, resulting in recurrent diseases. Therefore, a better understanding of the stress-induced susceptibility to HSV-1 primary infection and reactivation is needed and will provide helpful insights into the effective control and treatment of HSV-1. Here we reviewed the recent advances in the studies of HSV-1 susceptibility, latency and reactivation. We included mechanisms involved in primary infection and the regulation of latency and described how stress-induced changes increase the susceptibility to primary and recurrent infections.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

  • 文章类型: Journal Article
    证明了通过改变标记底物的亚细胞定位来测定体内蛋白水解活性的方法。该测定包括在不同细胞区室之间穿梭的蛋白质和位点特异性重组蛋白酶。使用的穿梭蛋白是人类免疫缺陷病毒1型(HIV-1)Rev蛋白与增强的绿色荧光蛋白(EGFP)和红色荧光蛋白(RFP)串联融合,而蛋白酶是来自1型单纯疱疹病毒(HSV-1)的位点特异性蛋白酶VP24。Rev融合蛋白中的荧光蛋白通过对VP24蛋白酶特异的切割位点分离。当在COS-7细胞中共表达时,通过荧光显微镜观察到蛋白水解从融合蛋白RevEGFP的主要细胞质定位转变为核定位,而融合蛋白的RFP部分保留在细胞质中。通过蛋白质印迹分析证实VP24对融合蛋白的切割。VP24的活性,当用Myc表位标记N端时,与VP24相当。这些结果表明,重组表达的蛋白酶的活性和定位可以通过蛋白酶介导的含有特定蛋白酶切割位点的融合蛋白的切割来评估。
    An approach to assay proteolytic activity in vivo by altering the subcellular localization of a labelled substrate was demonstrated. The assay included a protein shuttling between different cellular compartments and a site-specific recombinant protease. The shuttle protein used was the human immunodeficiency virus type 1 (HIV-1) Rev protein tandemly fused to the enhanced green fluorescent protein (EGFP) and the red fluorescent protein (RFP), while the protease was the site-specific protease VP24 from the herpes simplex virus type 1 (HSV-1). The fluorescent proteins in the Rev fusion protein were separated by a cleavage site specific for the VP24 protease. When co-expressed in COS-7 cells proteolysis was observed by fluorescence microscopy as a shift from a predominantly cytoplasmic localization of the fusion protein RevEGFP to a nuclear localization while the RFP part of the fusion protein remained in the cytoplasm. The cleavage of the fusion protein by VP24 was confirmed by Western blot analysis. The activity of VP24, when tagged N-terminally by the Myc-epitope, was found to be comparable to VP24. These results demonstrates that the activity and localization of a recombinantly expressed protease can be assessed by protease-mediated cleavage of fusion proteins containing a specific protease cleavage site.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

公众号